京东健康（06618）今日盘中大涨5.08%，引发市场关注。截至发稿，该股报40.65港元，成交额超2亿港元。
京东健康近期公布的2025年第一季度财报显示，公司业绩表现亮眼。当季实现收入166.45亿元，同比增长25.5%；经营盈利达10.71亿元，同比大幅增长119.8%。此外，公司在业务领域也取得多项进展，包括推出"AI京医"产品体系，并在线首发多款创新药品。
受此利好消息影响，高盛发布研报上调京东健康目标价至42.5港元，维持"买入"评级。高盛认为京东健康第一季度收入和利润超出预期，主要受益于药品和营养产品强劲增长及毛利率提升。分析师预计，京东健康将在药品类别中扩大市占，并受益于实时需求的流量增长，因此上调了对公司2025年至2027年的收入和利润预测。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.